Methods: 33 patients with advanced breast cancer were studied.
方法：33例晚期乳腺癌患者。
Objective To evaluate the effect of paclitaxel combined DDP on advanced breast cancer.
目的评价紫杉醇联合顺铂对晚期乳腺癌的治疗作用。
Objective To study the clinical effect of neoadjuvant chemotherapy on advanced breast cancer.
目的探讨新辅助化疗在晚期乳腺癌治疗中的效果。
Methods Of the 156 advanced breast cancer patients, 83 had had MTT assay before chemotherapy.
方法156例晚期乳癌病人中，83例在化疗前接受了MTT体外药敏试验。
Dr. Sandra Levy of the Pittsburgh cancer Institute studied women with advanced breast cancer.
匹兹堡肿瘤研究所的桑德·拉拉·利维博士对患乳腺癌的妇女进行了研究。
So if we go back, for example, to the drug bevacizumab in connection with advanced breast cancer...
因此，让我们回到抗癌药物上来，例如，晚期乳腺癌的药物-贝伐株单抗。
Methods The clinical data of 54 cases with advanced breast cancer were analyzed retrospectively.
方法对54例晚期乳腺癌患者进行观察。
ObjectiveTo explore the efficacy and safety of CAP regimen in the treatment of advanced breast cancer.
目的探讨CAP治疗晚期乳腺癌的疗效和安全性。
Currently, medical textbooks estimate the median survival for advanced breast cancer to be 2 to 3 years.
目前，医学教科书估计的晚期乳腺癌中位生存期为2年至3年。
Objective:To test Lentaron's effect and side effect in postmenopausal women with advanced breast cancer.
目的：验证进口新药兰特隆对绝经后妇女晚期乳腺癌的临床抗肿瘤活性及不良反应。
Objective: to observe the effects and toxicity of docetaxel plus DDP in treatment of advanced breast cancer.
目的：观察国产多烯紫杉醇联合顺铂治疗晚期乳腺癌的疗效及毒副反应。
Objective: To evaluate the effect of neoadjuvant chemotherapy in the treatment of locally advanced breast cancer.
前言： 目的：探讨新辅助化疗在局部晚期乳腺癌治疗中的应用。
This review presents the present state and future prospect of neoadjuvant chemotherapy for advanced breast cancer.
现就新辅助化疗在乳腺癌治疗中的现状及展望作一综述。
Objective: to evaluate the effect and side effect of mitoxantrone combination chemotherapy for advanced breast cancer.
目的：观察以米托蒽醌为主的联合化疗治疗晚期乳腺癌的近期疗效与毒性反应。
Methods: 32 patients with locally advanced breast cancer treated by neoadjuvant chemotherapy were reviewed retrospectively.
方法：回顾性分析32例局部晚期乳腺癌患者进行新辅助化疗的临床资料。
Conclusions:Combination of the Magical power of trichosanthes and chemotherapy is a good treatment in advanced breast cancer.
结论：神效栝蒌散联合西药化疗方案对晚期乳腺癌患者而言是一个很好的治疗方案。
The guidelines were finalized at the first Advanced Breast Cancer (ABC1) consensus conference, held November 3 to 5 in Lisbon.
新指南在11月3日至5日在里斯本举行的第一次晚期乳腺癌(ABC1)会议上定稿。
Stephen merrill another mathematician at marquette recently studies bone marrow transplants in the treatment of advanced breast cancer.
史蒂芬马芮尔是马奎特大学另一位数学家，最近研究治疗晚期乳癌的骨髓移植疗法。
In one well-known study, for example, patients with advanced breast cancer who underwent group therapy lived longer than those who did not.
在一项众所周知的研究中，患有严重乳腺癌病人中，接受心理治疗的人比那些没有治疗的人存活的时间要长。
CONCLUSIONS: HEP regimen was modestly active in advanced breast cancer failed chemotherapy previously. It can be a choice for these patients.
结论：HEP方案对先前反复化疗失败的晚期乳腺癌有一定疗效，是可选择的治疗方案之一。
Conclusions ca regimen is as good as CAF regimen in the management of advanced breast cancer, and the toxicities were lower than CAF regimen.
CA方案胃肠道反应较CAF轻。结论CA方案与CAF方案均是治疗晚期乳腺癌的较佳方案，对晚乳腺癌有较高的缓解率和较低的毒副作用。
Objective to evaluate the relation of dose intensity and efficacy, toxicity in advanced breast cancer treated with paclitaxel as a single agent.
目的分析单药紫杉醇治疗晚期乳腺癌剂量强度与疗效和毒性的关系。
Conclusion Neo-adjuvant chemotherapy with ET regimen for 4 cycles were more effective than 2 cycles to down staging locally advanced breast cancer.
结论ET方案对局部进展期乳腺癌进行新辅助化疗，在肿瘤及淋巴结缩小（降期）效果方面，4周期组明显优于2周期组。
Objective:To investigate the effect of regional perfusion on histology of advanced breast cancer and to explore the possibility of radical operation.
目的：观察区域性灌注化疗对晚期乳腺癌组织学的影响，以探讨根治性手术的可能性。
The neoadjuvant chemotherapy and regular endocrine therapy are the necessary measures to improve the survival rates of locally advanced breast cancer.
术前辅以新辅助化疗，术后辅以正规内分泌治疗是提高局部晚期乳腺癌生存率的必要手段。
Objective To study the value of pre-operative chemotherapy combined with breast conservation surgery for the treatment of middle-advanced breast cancer.
目的研究新辅助化疗在中晚期乳腺癌保乳治疗中的应用价值。
In patients stricken with advanced breast cancer, the disease can rage like a wildfire, jumping from hot spot to hot spot, sparking pain and disability.
在受灾患者晚期乳腺癌，这种疾病可以愤怒，如野火，跳楼，从热点到热点，引起疼痛和残疾。
Late last month, federal drug regulators gave their answer when they approved a drug called Avastin for treatment of patients with advanced breast cancer.
上个月底，联邦药品监管机构给予他们的答案时，他们批准了一项所谓的药物阿瓦斯丁用于治疗晚期乳腺癌。
Late last month, federal drug regulators gave their answer when they approved a drug called Avastin for treatment of patients with advanced breast cancer.
上个月底，联邦药品监管机构给予他们的答案时，他们批准了一项所谓的药物阿瓦斯丁用于治疗晚期乳腺癌。
应用推荐